Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
MDCK cells treated with YM-201636 accumulate the tight junction protein claudin-1 intracellularly
Derazantinib inhibits FGF-mediated loss of extracellular matrix and induction of chondrocyte premature senescence
Nocodazole was used at 200 ng/ml in vitro and cellular assays
1-O-acetylbritannilactone (1)
BB 94 sodium salt
CRA-2059 Catalog No.:M13228-10 MDCK cells treated with YM-201636CRA 2059 is a highly specific and selective tryptase inhibitor, with a Ki of 620 pM for recombinant human tryptase (rHT). Product information CAS Number: 256649 36 2 Molecular Weight: 750. 80 Formula: C34H46N12O8 Chemical Name: (3R,6R) 6 (4 {[(4 carbamimidamidophenyl)methyl]carbamoyl}piperazine 1 carbonyloxy) hexahydrofuro[3,2 b]furan 3 yl 4 {[(4 carbamimidamidophenyl)methyl]carbamoyl}piperazine 1 carboxylate Smiles: